Background
algorithm, was used for modeling gene expression through dimensionality reduction in many studies [13] [14] [15] . Lin et al. proposed a supervised neural network model for singlecell RNA-seq data that incorporate protein-protein interaction (PPI) and protein-DNA interaction (PDI) information. However, the prior biological knowledge was only utilized to improve the performance of dimensionality reduction and cell type-specific identification, the influence of combining PPI nodes was not examined.
In this study, we proposed Gene Superset AutoEncoder (GSAE), a multi-layer autoencoder model that incorporates a priori defined gene sets to preserve the crucial biological features from combining gene sets in the latent layer. We introduced the concept of the gene superset, an unbiased combination of gene sets, with weights trained by the autoencoder, where each node in the latent layer is termed a superset. The goal of this study is to determine the functional or clinical relevance of the learned gene supersets from our model, where the model evaluates gene expression data at the level of superset.
To achieve our goal, we used large-scale RNA-seq data sets from The Cancer Genome Atlas (TCGA) to test GSAE and investigate the top ranked gene sets in the statistically significant supersets. We demonstrated that gene supersets preserve sufficient biological information with respect to tumor subtypes and clinical prognostic significance. Our study also compared different neural network classifiers and the superset classifier showed high accuracy in cancer subtype prediction. We concluded that superset produces more reproducible results than single gene sets, provides robustness in cancer subtype classification, and has the capability to learn potential gene sets association.
Materials and Methods

Data sets in this study
For Pan-cancer (PanCan) analysis, we collected TCGA RNA-seq data that was organized by TumorMap [16] , which contains 9,806 samples in 33 cancer types. In addition to entire TCGA data, we also selected breast invasive carcinoma (BRCA) data with 1,099 samples for characterizing network nodes. For survival analysis, lung adenocarcinoma (LUAD) with 515 samples were chosen. Furthermore, we used four data sets with sufficient survival information, LUAD, BRCA, lower grade glioma (LGG, 523 samples), and skin cutaneous melanoma (SKCM, 469 samples) to compare the reproducibility of supersets and gene sets. The expression profiles of all tumor RNA-seq in this study are in the Transcripts Per Million (TPM) unit and then log-transformed (logTPM = log2(TPM + 1)), which are re-analyzed uniformly for all samples [16] .
Gene superset autoencoder
The architecture of GSAE is shown in Fig. 1 
where the bias b and the weight w are the two parameters that are learned in training, g() is the activation function, where we used the linear activation in the output layer and rectified linear unit (ReLU, defined in Eq. 2) in other layers to provide non-linearity while keeping a scoring feature in the model.
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Besides the input layer in our proposed autoencoder, the first two layers are the encoding network that extracts the important features from gene expression. ReLU activation mimics pathway activation/deactivation function, and comparing with with linear activation in all layers, GSAE with ReLU activation in the hidden layers has much better performance in cancer subtype prediction (data not shown). The decoder part comprises the last two layers; it is a complementary function of the encoder, and it aims to reconstruct the input from the converge layer. If the model is designed as a neural network-based classifier for cancer subtype prediction, the decoder network is replaced by a softmax function that is used as the output layer. At last, we choose the loss function to be either a mean square error function for the reconstruction loss, or a categorical cross-entropy function for multi-class classification error.
Incorporate gene sets into the encoder layer
We designed the first layer in the encoder as the gene set layer, which incorporates the information of a collection of gene sets. Specifically, each node in this layer represents a gene set, where only genes in the input layer that belong to a gene set have connection to the node [13] , and the weight for each connection is determined by the backpropagation in training steps. This is different from the fully connected layer commonly used in 
Resolve dependencies among gene sets
The CGP collection in MSigDB includes the gene sets that represent expression signatures of genetic and chemical perturbations published in literature. However, some gene sets are highly similar, and we need to mitigate the dependency. We used a similar method as in our previous study [18] to cluster gene sets with significant similarity. First, we omitted the gene sets that have less than 15 or more than 500 genes, which is also the default setting in original GSEA implementation [1] . We subsequently used kappa statistics to measure the similarity between all gene sets. We clustered gene sets with Pvalue < 10 -7 , and assigned the largest gene set as the representative of the cluster. At last, there are 2,334 CGP gene sets including 18,107 genes selected to form the gene set layer.
Establish and train the gene superset autoencoder
We implemented the model using Keras 1.2.2 (https://github.com/fchollet/keras) and used the custom layer method in Keras to accomplish the sparsity of gene set layer in order to keep the zero weights while optimizing the parameters. Since ReLU is used as the activation function, we selected He uniform initialization as the initializers for all layers [19] . To train the autoencoder, we used the stochastic gradient descent (SGD)
optimizer that was revised in Lin et al. study [13] , which was designed to deal with the optimization problem for sparse layers. The SGD parameters were set as following, learning rate = 0.05, decay = 10 -6 , momentum = 0.9, and Nesterov = 1.
While training the model for a data set, we extracted 5% of data to be the validation set to avoid overfitting. With the callbacks.EarlyStopping() function in Keras, the model stops training when the loss of validation split doesn't improve in three consecutive epochs. At last, we imported the data set into the trained model and exported the outputs and weights of the encoder layers for further analyses in R.
The use of additional machine learning tools
In this study, we have applied t-Distributed Stochastic Neighbor Embedding (t-SNE, https://cran.r-project.org/package=Rtsne) [20, 21] , which has been widely used for dimensionality reduction. We performed t-SNE on superset results and embedded the high-dimensional data into a two-dimensional space, where potential subpopulations of the data were revealed. Another machine learning method, Hierarchical Density-Based Comparing with many other clustering algorithms, HDBSCAN has good performance and stability in exploratory data analysis. We performed HDBSCAN on the t-SNE results to determine the possible clusters among the data. Ambiguous samples were classified as noise and omitted from further analysis.
Differential superset analysis between tumor subtypes
After performing t-SNE on the superset layer outputs, we subsequently determined the subtypes of a data set by using HDBSCAN. To find the supersets with a subtype pattern, we compared superset values between one tumor subtype (group 1) and the other subtypes (group 2) by one-tailed Mann-Whitney-Wilcoxon U test (MWW) with a location shift of "mu" (mu was assigned to change the stringency of the test). Significant supersets (MWW P-value < 0.01) that have larger values in group 1 were named as upsupersets, whereas down-supersets were the significant supersets with larger than in group 2. We further investigated gene sets in the significant supersets. To quantify the contribution of i th gene set in j th superset, gsScore was calculated as following,
where µ 1 and µ 2 are the average of the i th gene set values in the two groups, and w ij is the weight in the model corresponding to the connection from the i th gene set to the j th superset. In up-supersets, gene sets with gsScore greater than a positive cutoff (in the right tail) were selected. In the opposite, gene sets in the down-supersets with gsScore less than a negative cutoff (in the left tail) were selected. Those gene sets are the potential high impact gene sets of the subtype (group 1).
Kaplan-Meier Survival analysis on superset layer
To discover whether GSAE retains survival related features; for each superset and gene set, we used a median split (median of the superset or gene set value) to create two groups and performed log-rank test. For each prognostic significant superset, we ranked gene sets according to the gsScore (Eq. 3) and further investigated the survival relevance of top gene sets.
Results
Cancer type information Preserved in low dimension outcome
To test the capability of GSAE to retain crucial features in the superset layer, we used TCGA PanCan RNA-seq logTPM data, 15,975 genes selected with µ > 1 and σ > 0.5 across 9,806 samples in 33 cancer types, as GSAE inputs and exported the superset layer results. We performed t-SNE on TCGA logTPM data and the superset layer outputs (200 nodes), and the results are shown in Fig. 2 , in which the color of each node was labelled according to the cancer type information. The groupings of cancer types in the two t-SNE plots are nearly identical, where most cancer types form an individual cluster. The mingling of few cancer types are also similar in both figures. We concluded that the model is able to retain cancer type features of a data while reducing dimensionality.
Indication of gene sets associated with breast cancer subtypes
In Fig.2 , we learned that the samples labeled in red are separate into two clusters, and we further verified that they belonged to BRCA. We used GSAE to analyze the BRCA data separately to discover gene sets that are support this subtype differentiation. There were 15,183 genes in 1,099 samples that meet the criterion of µ > 1 and σ > 0.5, where they were used as the model input. After training of the model, we exported the superset results and performed t-SNE, which is shown in Fig. 3A . We applied HDBSCAN, which clustered the samples into two groups, where group 1(G1) is labeled in red and group 2 (G2) in green. The noisy samples defined by the algorithm were omitted. Four upsupersets and three down-supersets were determined (P-value < 0.01) using one-tailed
Mann Whitney U test with location shift mu = 9, where only supersets with a huge difference between the two groups could pass the test. In each significant superset, those with gsScore > 2 sd (standard deviation of all gsScores in the superset) are the high impact gene sets of the superset. All high impacts gene sets of 7 significant supersets are listed in table S1, and the PScore (-log 10 (P-value)) of Mann Whitney U test (location shift set as 0.5) of each gene set was also included. Group 1 has a higher value in "DOANE_BREAST_CANCER_ESR1_DN", which matches the gene set condition where these genes were down-regulated in ESR1 positive samples [26] . Genes that are involved in "PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7" differentiates the HER2
positive and negative BRCA subtype [27] . A study has shown that c-Myb differed significantly across the subtypes, where Basal-like has the lowest expression [28] , which fits the result of "LEI_MYB_TARGETS". There is no direct connection of Estradiol with breast cancer subtype, but it is an estrogen and its target gene set "FRASOR_RESPONSE_TO_ESTRADIOL_DN" might be a potential subtype marker.
After reviewing these gene sets, because the Basal subtype accounts for 15% of the breast cancer population, we hypothesized that G1, the small subpopulation in red in Fig.   3A , is the Basal subtype of breast cancer. We checked the TCGA clinical information and PAM50 classification results and verified that 156 of 175samples (with complete estrogen status or PAM50 subtype information) in G1 are either Basal-like or triple negative samples. This result demonstrates that our proposed superset autoencoder is able to reveal the subpopulation features and biological relevance.
We compared with GSEA results between G1 and G2, and 53 out of 124 (42.7%) high impact gene sets are also GSEA enriched gene sets (nom P-value < 0.05), which indicates the reliability of our results. To examine whether a superset contains some exclusive gene sets, we compared the top 3 up-supersets (Table S1A -C) and the Venn diagram is shown in Fig. 3D . Many of the overlapped gene sets are associated with the Basal subtype (12 common gene sets in Table S1 , bold font). Up-superset 1 has additional estrogen related gene sets (Table S1A , colored in blue); up-superset 2 holds some gene sets that are relevant to ERBB2 (Table S1B , colored in blue).
Prediction of breast cancer PAM50 subtypes with superset classifier
To test if our model can be used as a classifier to predict cancer subtypes, we reconstructed our model to the architecture shown in Fig. S1A , where the decoder network is replaced by a softmax function output (input -encoder -prediction output).
With the clinical annotation organized by the UCSC Cancer Genomics Browser [29, 30] (captured in 2015, https://genome-cancer.ucsc.edu), we selected 821 BRCA samples with 15,183 genes in Basal, LumA, LumB, and Her2 PAM50 subtypes as input data to test the performance of the superset classifier (normal-like subtype was removed due to small sample size). Using 10-fold cross validation to test the superset classifier, we achieved a good performance of 88.79% prediction accuracy.
With the same input, we also compared with four different neural network models, 1) gene set classifier, in which the superset layer is removed (Fig. S1B ), 2) 2-layer fully connected encoder network with the same size of the superset classifier ( Table 3 . We have tuned the SGD parameter setting of each model in order to get the best performance.
The prediction accuracy of gene set classifier (87.69%) is close to that of the superset classifier, which implies the gene set layer contains sufficient information for classification. On the other hand, all three classifiers with fully connected encoder has low prediction accuracy (<50%), mainly due to the large number of weights need to be trained to attain (or fail to attain) an optimal model. To alleviate the training burden, we reduced the input number by performing principal component analysis (PCA) on BRCA data first and selected top 500 principal components (PCs) to test the models with fully connected encoder (layer size was also optimized by Hyperas, Table 3 genes in 515 samples were used as the model input. We also organized the TCGA LUAD survival information to a 5-year survival record, where the maximum survival time was set as 1,825 days, and a death event that occurred after five years was counted as a censored event. After performing log-rank test on the superset results, we determined 6 supersets with log-rank P-value < 0.001, which were considered as prognostic significant nodes. We ranked the gene sets in those six supersets by the gsScore, and the top 20 gene sets in each superset are listed in Table S2 . The top ranked gene sets that also showed significance in gene set log-rank test were selected to probe the biological relevance of lung adenocarcinoma.
We picked the first and fourth ranked supersets as two examples, and the top 15 gene sets in the two supersets are listed in Table 4 and 5. We chose the 4 th ranked superset due to the least overlap of significant gene sets with the 1 st ranked superset. We selected three gene sets tested significant by the log-rank test from the two supersets and plotted the Kaplan-Meier survival curves in Fig. 4 . In rank 1 superset, several significant gene sets are related to the survival of LUAD. A study has shown that decreased mRNA expression of TCF21, a tumor suppressor, is a core predictor for poor prognosis in patients with lung cancers in two studies [32] [33] [34] , agree with what we found the prognosis association from TCGA LUAD with gene set "CUI_TCF21_TARGETS_2_UP" (P = 1.30×10 -4 ).
"KIM_WT1_TARGETS_DN" (P = 0.0064) is related to the oncogene WT1 in lung cancer, and the high expression of WT1 links to an unfavorable impact on the prognosis
[35]. We also found some gene sets that no previous study showed direct connection with the prognosis of LUAD. Previous studies have revealed that ETS-related transcription factors are associated with non-small-cell lung cancers (NSCLC) [36, 37] . ELK3 is also an ETS transcription factor, and the related gene set From the two selected supersets, we already found some gene sets highly associated with LUAD survival, there are some novel prognostic gene set candidates that need to be further studied. In conclusion, superset results encompass survival-associated features and sort out the priority of potential prognostic gene sets.
Improved survival reproducibility from supersets
To compare the reproducibility of survival results between the superset and gene set layers, we selected four TCGA data sets (BRCA, LUAD, SKCM, and LGG) to examine the reproducibility of GSAE. For each data set, we omitted genes that did not meet the criterion of µ > 1 and σ > 0.5. We next randomly split 60% of the data as the training set and the remaining 40% as the test set. After the autoencoder was trained on the training set, we obtained the superset outputs for the training and test sets. Median split and logrank test were performed on training and test superset results to determine survivalrelated supersets and gene sets.
We assumed that the prognostic significant gene sets and supersets should be similar between training and test data. To evaluate the performance of gene set and superset results, we compared the significant gene sets and supersets obtained from training data and those from test data by Jaccard index. Furthermore, we used two population proportions z-test to examine whether supersets have greater overlap proportion in the training data, and the results are shown in Table 6 .
In the largest data set BRCA, we found out that superset has much higher Jaccard index (34%) than gene set (12%), and the two overlap proportions differ significantly (P = 2×10 -4 ). In two other smaller data sets, LUAD and SKCM, superset (Jaccard Index ~18%) still outperforms gene set (11% and 7% for LUAD and SKCM, respectively; ztest P-value < 0.05). In LGG, because of the large number of prognostic significant nodes for superset and gene sets, both Jaccard coefficients are high (~48% for both superset and gene set) and the performance of gene set and superset is identical. To avoid the potential of sampling bias, we repeated the whole process in BRCA and LUAD several times, and we obtained similar stability measure (z-test P-value, data not shown). Overall, we concluded that superset has better reproducibility performance over gene set.
Discussion
Same as other machine learning algorithms, the selective process of GSAE is an issue.
Despite getting identical losses, different nodes (or gene sets) in different training may selective activated or de-activated (output value ~0) with the same training data. Take our study for example, we might obtain the same outcome (e.g. tumor subtype classification) of a dataset in the superset layer, but it is difficult to match superset between runs, and the top ranked gene set components in significant supersets might also be different, although highly relevant gene sets appear more frequent. This observation can be used to assess the significance of a given gene set or superset to a specific aim (e.g. survival association).
We also tried to understand the major cause of selective process in our model, and two The concept of gene supersets not only provides better reproducibility, it also gives us a chance to understand the inter-dependency of gene sets. In this study we investigated the associations between significant supersets and gene sets. However, relations between those top ranked gene sets in the same superset has yet to be discussed. One possible solution is to find the corresponding input genes that have large contribution to a significant superset (by interpreting the weights in the first layer as the gene weights in each gene set), where we can further form a set of genes based on the superset. All these alternative approaches will guide our future study to bolster the biological functions of supersets.
Conclusions
In this paper, we proposed a multi-layer autoencoder model with the incorporation of 
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